<DOC>
	<DOCNO>NCT00346515</DOCNO>
	<brief_summary>Multicenter , prospective , feasibility study design demonstrate performance safety Lumen Biomedical , Inc. FiberNet™ Embolic Protection System adjunctive device carotid artery percutaneous intervention use Guidant Acculink carotid stent high surgical risk patient .</brief_summary>
	<brief_title>EPIC US Feasibility Study : Use FiberNet® Emboli Protection Device Carotid Artery Stenting</brief_title>
	<detailed_description />
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>One high surgical risk criterion . Candidate percutaneous stenting target lesion locate within common internal carotid artery . Symptomatic atherosclerotic stenosis ≥ 50 % asymptomatic atherosclerotic stenosis ≥ 70 % carotid artery NASCET Criteria . Allergy Heparin . Myocardial infarction within last 14 day . Angioplasty PTCA/PTA procedure within past 48 hour . Cardiac surgery within past 60 day . Planned invasive surgical procedure within 30 day . Stroke within past 14 day . Transient ischemic neurological attack ( TIA ) amaurosis fugax within past 48 hour . Intracranial stenosis exceed severity extracranial stenosis . Peripheral vascular disease sufficient severity prevent vascular access target lesion . Total occlusion target vessel . Lesion within 2cm ostium common carotid artery . A stenosis know unsuitable stenting one : 1 . Tortuous calcified anatomy proximal distal stenosis 2 . Presence visual thrombus 3 . Pseudo occlusion ( 'string sign ' ) Serial lesion require one stent cover entire lesion . Procedural complication prior introduction FiberNet device body .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>carotid artery</keyword>
	<keyword>carotid stenosis</keyword>
	<keyword>carotid stenting</keyword>
	<keyword>embolic protection</keyword>
</DOC>